Chen YM - Search Results

1

Consensus statement and recommendations on the treatment of COVID-19: 2021 update.

Ko HK, Yu WK, Pan SW, Chen WC, Yang KY, Lin YT, Wang FD, Yang MH, Chen YM; Research Center for Epidemic Prevention—National Yang Ming Chiao Tung University (RCEP-NYCU). Ko HK, et al. Among authors: chen ym, chen wc. J Chin Med Assoc. 2022 Jan 1;85(1):5-17. doi: 10.1097/JCMA.0000000000000617. J Chin Med Assoc. 2022. PMID: 34524227 Review.

2

Clinical experience with single-agent gemcitabine chemotherapy in patients with non-small-cell lung cancer in whom previous chemotherapy has failed.

Chen YM, Tsai CM, Perng RP. Chen YM, et al. J Chin Med Assoc. 2005 Apr;68(4):163-6. doi: 10.1016/S1726-4901(09)70242-4. J Chin Med Assoc. 2005. PMID: 15850065 Free article. Clinical Trial.

3

Third-line or fourth-line chemotherapy in non-small-cell lung cancer patients with relatively good performance status.

Chen YM, Shih JF, Fan WC, Wu CH, Chou KT, Tsai CM, Lee YC, Perng RP, Whang-Peng J. Chen YM, et al. J Chin Med Assoc. 2011 May;74(5):209-14. doi: 10.1016/j.jcma.2011.03.005. Epub 2011 Apr 9. J Chin Med Assoc. 2011. PMID: 21550007 Free article.

4

Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer.

Chen YM. Chen YM. J Chin Med Assoc. 2013 May;76(5):249-57. doi: 10.1016/j.jcma.2013.01.010. Epub 2013 Mar 22. J Chin Med Assoc. 2013. PMID: 23683257 Free article. Review.

5

The epidermal growth factor receptor-tyrosine kinase inhibitor era has changed the causes of death of patients with advanced non-small-cell lung cancer.

Wu WS, Chen YM, Tsai CM, Shih JF, Lee YC, Perng RP, Whang-Peng J. Wu WS, et al. Among authors: chen ym. J Chin Med Assoc. 2013 Dec;76(12):682-5. doi: 10.1016/j.jcma.2013.08.006. Epub 2013 Sep 21. J Chin Med Assoc. 2013. PMID: 24064329 Free article.

6

Latent TB infection in newly diagnosed lung cancer patients - A multicenter prospective observational study.

Fan WC, Ting WY, Lee MC, Huang SF, Chiu CH, Lai SL, Chen YM, Shih JF, Lin CH, Kao SJ, Wu MF, Tsao TC, Wu CH, Yang KY, Lee YC, Feng JY, Su WJ. Fan WC, et al. Among authors: chen ym. Lung Cancer. 2014 Sep;85(3):472-8. doi: 10.1016/j.lungcan.2014.07.001. Epub 2014 Jul 9. Lung Cancer. 2014. PMID: 25063540

7

Latent Tuberculosis Infection and the Risk of Subsequent Cancer.

Su VY, Yen YF, Pan SW, Chuang PH, Feng JY, Chou KT, Chen YM, Chen TJ, Su WJ. Su VY, et al. Among authors: chen ym, chen tj. Medicine (Baltimore). 2016 Jan;95(4):e2352. doi: 10.1097/MD.0000000000002352. Medicine (Baltimore). 2016. PMID: 26825880 Free PMC article.

8

Immune checkpoint inhibitors for nonsmall cell lung cancer treatment.

Chen YM. Chen YM. J Chin Med Assoc. 2017 Jan;80(1):7-14. doi: 10.1016/j.jcma.2016.08.005. Epub 2016 Sep 29. J Chin Med Assoc. 2017. PMID: 27693088 Free article. Review.

9

First-line combination immunotherapy for metastatic non-small cell lung cancer.

Chen YM. Chen YM. J Chin Med Assoc. 2020 May;83(5):433-441. doi: 10.1097/JCMA.0000000000000287. J Chin Med Assoc. 2020. PMID: 32132380 Review.

10

Non-small cell lung cancer in the very young: Higher EGFR/ALK mutation proportion than the elder.

He CH, Shih JF, Lai SL, Chen YM. He CH, et al. Among authors: chen ym. J Chin Med Assoc. 2020 May;83(5):461-465. doi: 10.1097/JCMA.0000000000000311. J Chin Med Assoc. 2020. PMID: 32221155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,857 results

Search Page